Prevotella contributes to inflammation by producing lipopolysaccharide (LPS), which can trigger Toll-like receptor 4 (TLR-4), leading to low-grade inflammation and diarrhea-predominant irritable bowel syndrome (IBS) [72,73]. Here, TLR4 is linked to irritable bowel syndrome.